Dr. Sivarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2614 W. Jefferson St.
Joliet, IL 60435Phone+1 815-725-1355Fax+1 815-725-9861
Summary
- Dr. Kulumani Sivarajan is an oncologist in Joliet, IL and is affiliated with multiple hospitals in the area, including Morris Hospital & Healthcare Centers, AMITA Health Mercy Medical Center, AMITA Health Saint Joseph Hospital, Silver Cross Hospital, and AMITA Health Saint Joseph Medical Center. He received his medical degree from Jawaharlal Institute of Postgraduate Medical Education and Research and has been in practice 41 years. He is experienced in infection-induced thrombocytopenia, chronic neutrophilic leukemia, hodgkin's lymphoma, anemia of chronic kidney disease, and anemia of blood loss.
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1984 - 1985
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 1980 - 1982
- Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 1976
Certifications & Licensure
- AZ State Medical License 2022 - 2025
- IL State Medical License 1981 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsChange in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report.Lakshmi Sivarajan, Kulumani M. Sivarajan, Joseph Natarelli, Farrukh Aijaz
Case Reports in Oncology. 2011-01-18
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: